Control of tissue growth and cell transformation by the Salvador/Warts/Hippo pathway

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Zhang, Xiaomeng ^a,b   Grusche, Felix A ^a,b   Harvey, Kieran F ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; HIPPO PROTEIN; SALVADOR PROTEIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; WARTS PROTEIN; YES ASSOCIATED PROTEIN; YORKIE PROTEIN; CELL CYCLE PROTEIN; DROSOPHILA PROTEIN; HPO PROTEIN, DROSOPHILA; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; SALVADOR PROTEIN, DROSOPHILA; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR; WARTS PROTEIN, DROSOPHILA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE MUTATION; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TISSUE GROWTH; TRANSACTIVATION; TRANSCRIPTION REGULATION; ANIMAL; CYTOLOGY; DROSOPHILA MELANOGASTER; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TRANSCRIPTION INITIATION;

ANIMALS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84863139267     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031994     Document Type: Article

References (38)

1. Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, et al. (2002) salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110: 467-478.
2. Harvey K, Tapon N, (2007) The Salvador-Warts-Hippo pathway- an emerging tumour-suppressor network. Nat Rev Cancer 7: 182-191.
3. Halder G, Johnson RL, (2011) Hippo signaling: growth control and beyond. Development 138: 9-22.
4. Pan D, (2010) The hippo signaling pathway in development and cancer. Dev Cell 19: 491-505.
5. Huang J, Wu S, Barrera J, Matthews K, Pan D, (2005) The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122: 421-434.
6. Dong J, Feldmann G, Huang J, Wu S, Zhang N, et al. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133.
7. Zhao B, Wei X, Li W, Udan RS, Yang Q, et al. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761.
8. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL, (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24: 72-85.
9. Grusche FA, Richardson HE, Harvey KF, (2010) Upstream regulation of the hippo size control pathway. Curr Biol 20: R574-582.
10. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, et al. (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A 103: 12405-12410.
11. Zhang X, Milton CC, Humbert PO, Harvey KF, (2009) Transcriptional output of the Salvador/warts/hippo pathway is controlled in distinct fashions in Drosophila melanogaster and mammalian cell lines. Cancer Res 69: 6033-6041.
12. Zhao B, Kim J, Ye X, Lai ZC, Guan KL, (2009) Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein. Cancer Res 69: 1089-1098.
13. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, et al. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17: 2054-2060.
14. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, et al. (2011) Yap1 Acts Downstream of alpha-Catenin to Control Epidermal Proliferation. Cell 144: 782-795.
15. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, et al. (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125: 1253-1267.
16. Hall CA, Wang R, Miao J, Oliva E, Shen X, et al. (2010) Hippo pathway effector Yap is an ovarian cancer oncogene. Cancer Res 70: 8517-8525.
17. Wang Y, Dong Q, Zhang Q, Li Z, Wang E, et al. (2010) Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci 101 (5): 1279-1285.
18. Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT, et al. (2009) Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115: 4576-4585.
19. Zhang X, George J, Deb S, Degoutin JL, Takano EA, et al. (2011) The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene 30: 2810-2822.
20. Zhao B, Ye X, Yu J, Li L, Li W, et al. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971.
21. Vassilev A, Kaneko KJ, Shu H, Zhao Y, DePamphilis ML, (2001) TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev 15: 1229-1241.
22. Ota M, Sasaki H, (2008) Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135: 4059-4069.
23. Wu S, Liu Y, Zheng Y, Dong J, Pan D, (2008) The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell 14: 388-398.
24. Zhang L, Ren F, Zhang Q, Chen Y, Wang B, et al. (2008) The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell 14: 377-387.
25. Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Silber J, et al. (2008) SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr Biol 18: 435-441.
26. Sudol M, Harvey KF, (2010) Modularity in the Hippo signaling pathway. Trends Biochem Sci 35: 627-633.
27. Oka T, Sudol M, (2009) Nuclear localization and pro-apoptotic signaling of YAP2 require intact PDZ-binding motif. Genes Cells 14: 607-615.
28. Sudol M, (1994) Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product. Oncogene 9: 2145-2152.
29. Yagi R, Chen LF, Shigesada K, Murakami Y, Ito Y, (1999) A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. Embo J 18: 2551-2562.
30. Hilman D, Gat U, (2011) The Evolutionary history of YAP and the Hippo/YAP pathway. Mol Biol Evol doi:10.1093/molbev/msr065.
31. Sebé-Pedrós A, Zheng Y, Ruiz-Trillo I, Pan D, (2012) Premetazoan Origin of the Hippo Signaling Pathway. Cell Reports 1: 1-8.
32. Lee T, Luo L, (1999) Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis. Neuron 22: 451-461.
33. Poon CL, Lin JI, Zhang X, Harvey KF, (2011) The Sterile 20-like Kinase Tao-1 Controls Tissue Growth by Regulating the Salvador-Warts-Hippo Pathway. Dev Cell 21: 896-906.
34. Grusche FA, Degoutin JL, Richardson HE, Harvey KF, (2011) The Salvador/Warts/Hippo pathway controls regenerative tissue growth in Drosophila melanogaster. Dev Biol 350: 255-266.
35. Dow LE, Elsum IA, King CL, Kinross KM, Richardson HE, et al. (2008) Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling. Oncogene 27: 5988-6001.
36. Chan SW, Lim CJ, Huang C, Chong YF, Gunaratne HJ, et al. (2011) WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ. Oncogene 30: 600-610.
37. Zhang X, Milton CC, Poon CL, Hong W, Harvey KF, (2011) Wbp2 cooperates with Yorkie to drive tissue growth downstream of the Salvador-Warts-Hippo pathway. Cell Death Differ 18: 1346-1355.
38. Oh H, Irvine KD, (2011) Cooperative regulation of growth by Yorkie and Mad through bantam. Dev Cell 20: 109-122.